Displaying drugs 7376 - 7400 of 13634 in total
O-(N-acetyl-alpha-D-galactosaminyl)-L-serine
Experimental
INBRX-101
INBRX-101 is a recombinant human alpha-1 antitrypsin (AAT)-Fc fusion protein.
Investigational
Matched Description: … INBRX-101 is a recombinant human alpha-1 antitrypsin (AAT)-Fc fusion protein. …
Tricosanoic acid
Experimental
NUC B1000
NUC B1000 is an expressed interfering RNA (eiRNA)- based product consisting of a plasmid DNA construct designed to produce four short interfering RNA (siRNA) molecules, formulated with a proprietary cationic-lipid delivery system. eiRNA is an approach to RNAi therapeutics, whereby a plasmid DNA coding for desired dsRNA is delivered to...
Investigational
Matched Description: … [F3910] eiRNA is an approach to RNAi therapeutics, whereby a plasmid DNA coding for desired dsRNA is ... experimental treatment for chronic Hepatitis B virus (HBV) infection. ... NUC B1000 is an expressed interfering RNA (eiRNA)- based product consisting of a plasmid DNA construct …
PA-1050040
PA1050040, a second generation HIV-1 maturation inhibitor, is a chemical analog of Bevirimat (BVM). It inhibits virus replication by the same mechanism of action as BVM.
Investigational
Matched Description: … PA1050040, a second generation HIV-1 maturation inhibitor, is a chemical analog of Bevirimat (BVM). …
S-adenosyl-L-homocysteine
5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions.
Experimental
PYM50018
PYM50018 is a patented, orally active, neuroprotective and neuroregenerative compound. It is developed for the treatment of amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease). In pre-clinical models, PYM50018 has been observed to protect against neuronal damage, increase neurite outgrowth, reverse oxidative damage and reverse neuronal apoptosis in...
Investigational
Matched Description: … It is developed for the treatment of amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease ... PYM50018 is a patented, orally active, neuroprotective and neuroregenerative compound. ... outgrowth, reverse oxidative damage and reverse neuronal apoptosis in vitro. …
Ticlatone
Experimental
Matched Categories: … Antifungals for Topical Use ... Antifungals for Dermatological Use …
Strontium malonate
Strontium malonate is being developed as a novel orally available pharmaceutical for the treatment and prevention of osteoporosis. It is being developed by Osteologix Inc.
Investigational
Matched Description: … Strontium malonate is being developed as a novel orally available pharmaceutical for the treatment and …
N(2)-succinyl-L-arginine
Experimental
Aluminium clofibrate
Experimental
MYR-101
MYR-101 (rAAV-Olig001-ASPA) is a recombinant adeno-associated virus (rAAV) vector-based gene therapy intended to treat Canavan disease. Canavan disease is a fatal childhood genetic disorder characterized by white matter degeneration in the brain. It is caused by a mutation in the aspartoacylase gene (ASPA), which leads to a deficiency of the...
Investigational
Matched Description: … It is caused by a mutation in the aspartoacylase gene (_ASPA_), which leads to a deficiency of the aspartoacylase ... Canavan disease is a fatal childhood genetic disorder characterized by white matter degeneration in the ... The FDA has granted MYR-101 Fast Track, Rare Pediatric Disease (RPD), and Orphan Drug designations for …
Sesame oil
Sesame oil is a commonly used vegetable oil in Asia and flavoring enhancer in various culinary practices. It is extracted from sesame seeds and contains linoleic acid, oleic acid, palmitic acid, stearic acid and other fatty acids. Sesame oil is reported to possess antioxidant, antiaging, antihypertensive, immunoregulatory and anticancer properties....
Investigational
Nutraceutical
Matched Description: … Sesame oil is a commonly used vegetable oil in Asia and flavoring enhancer in various culinary practices ... It has also shown to accelerate alcohol decomposition in the liver [A27257]. ... Sesame oil is considered an indirect additive used in food cotact substances by the FDA. …
Autogene cevumeran
Autogene cevumeran is an mRNA-based cancer vaccine targeting an unspecified amount of tumour-associated antigens. It is being investigated for cancers.
Investigational
Matched Description: … It is being investigated for cancers. …
(R)-3-hydroxytetradecanoic acid
Experimental
Denfivontinib
Investigational
SPP 301
SPP301 (Avosentan) is a potent and highly selective ET[A] receptor blocker and is clinically investigated in diabetic nephropathy. This study was designed to evaluate whether avosentan influences the pharmacokinetics of steroid oral contraceptives.
Investigational
Matched Description: … in diabetic nephropathy. ... SPP301 (Avosentan) is a potent and highly selective ET[A] receptor blocker and is clinically investigated …
N-Coeleneterazine
Experimental
Matched Iupac: … ,8S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-[(naphthalen-2-yl)methyl]-2H,3H,7H,8H-imidazo[1,2-a] …
Tetrahydrogestrinone
Experimental
Matched Iupac: … (1S,3aS,3bS,11aS)-1,11a-diethyl-1-hydroxy-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,11aH-cyclopenta[a]phenanthren …
Ozagrel
Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes.
Investigational
Matched Description: … Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes. …
Matched Categories: … Thromboxane-A Synthase, antagonists & inhibitors …
Matched Categories: … Thromboxane-A Synthase, antagonists & inhibitors …
(S)-2-Tetrahydrofuroic acid
Experimental
Caprylhydroxamic acid
Experimental
Isonicotinic acid
Investigational
Cobnabexagene anvuparvovec
Experimental
Displaying drugs 7376 - 7400 of 13634 in total